In a groundbreaking development, Russia’s Ministry of Health has announced the creation of a revolutionary mRNA-based cancer vaccine, set to be launched in early 2025.

The vaccine, which uses genetic material from a patient’s tumor, will be offered to patients at no cost.

According to Andrey Kaprin, head of the Radiology Medical Research Centre of the Ministry of Health, the vaccine aims to treat cancer patients rather than prevent tumor formation.

“The vaccine trains the immune system to recognize and attack cancer cells by using components from the patient’s tumour,” Kaprin explained.

READ ALSO:

Ibadan carnival tragedy: Govt. confirms loss of several children’s lives

Northern democrats outline conditions for supporting Tinubu’s Tax Bills

Naomi, Ooni’s Ex-Wife, arrested over Ibadan stampede, as Police confirm 35 children dead

The vaccine’s development is a significant step forward in cancer research and treatment. Alexander Gintsburg, director of the Gamaleya National Research Centre for Epidemiology and Microbiology, highlighted the challenges of creating personalized vaccines.

“Now it takes quite a long time to build personalised vaccines because computing using a vaccine, or customised mRNA, should look like using matrix methods, in mathematical terms,” Gintsburg said.

However, with the involvement of the Ivannikov Institute, the use of artificial intelligence (AI) is expected to significantly reduce the time required to develop customized vaccines.

“We have involved the Ivannikov Institute, which will rely on AI in doing this math, namely neural network computing, where these procedures should take about half an hour to an hour,” Gintsburg added.

The Russian government’s commitment to making the vaccine free is a significant gesture, especially considering the rising cancer cases in Russia. With over 635,000 new diagnoses reported in 2022, cancer has become a major health concern in the country.

Other nations, including the US and UK, are also working on their personalized cancer vaccines. Researchers at the University of Florida have tested a customized vaccine for patients with glioblastoma, a severe brain cancer, showing promising immune responses just two days post-injection.

As Russia prepares to launch its groundbreaking cancer vaccine, the international community is watching with interest.

With its potential to revolutionize cancer treatment, this development could be a game-changer in the fight against cancer.